Our study was conducted by searching TCGA and GEO databases, which showed that ALOX5AP was significantly upregulated in AML patients compared to a normal controls, and that high ALOX5AP expression associated with DNA hypomethylation were correlated with poor prognostic clinical and biological features. The gene discussed is ALOX5AP; the disease is acute myeloid leukemia.